The Role of Bioactive Peptides in Diabetes and Obesity

• Published in: Foods Vol. 10; no. 9; p. 2220
• Main Authors: Chelliah, Ramachandran, Wei, Shuai, Daliri, Eric Banan-Mwine, Elahi, Fazle, Yeon, Su-Jung, Tyagi, Akanksha, Liu, Shucheng, Madar, Inamul Hasan, Sultan, Ghazala, Oh, Deog-Hwan
• Format: Journal Article
• Language: English
• Published: Basel MDPI AG 18.09.2021; MDPI
• Subjects: Aging; Amino acids; anti-inflammatory; antimicrobial; antioxidant; Antioxidants; Arthritis; Barley; bioactive peptides; Biological activity; Blood pressure; Cancer; Cholesterol; Diabetes; Diabetes mellitus; Diabetes mellitus (non-insulin dependent); Disorders; Eggs; Enzymes; Food; Food processing; Food science; Hypertension; Innate immunity; Metabolic disorders; Metabolic syndrome; Metabolism; Milk; Narcotics; Obesity; Peptides; Physiology; Proteins; Proteolysis; Review; Rice; Therapeutic targets
• ISSN: 2304-8158; 2304-8158
• DOI: 10.3390/foods10092220

Bioactive peptides are present in most soy products and eggs and have essential protective functions. Infection is a core feature of innate immunity that affects blood pressure and the glucose level, and ageing can be delayed by killing senescent cells. Food also encrypts bioactive peptides and protein sequences produced through proteolysis or food processing. Unique food protein fragments can improve human health and avoid metabolic diseases, inflammation, hypertension, obesity, and diabetes mellitus. This review focuses on drug targets and fundamental mechanisms of bioactive peptides on metabolic syndromes, namely obesity and type 2 diabetes, to provide new ideas and knowledge on the ability of bioactive peptide to control metabolic syndromes.